By Lisa Rapaport May 21, 2021 (Reuters Health) – Taking proton pump inhibitors (PPIs) is associated with increased risk of developing gastric cancer regardless of Helicobacter pylori eradication status, a Korean study suggests. Researchers examined data in the Korean National Health Insurance Service database on 6,877 patients who initiated PPI therapy and 6,877 propensity matched controls who...